Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study

Conclusions:
Comorbidities at diagnosis should be taken into account at the first treatment choice because they are associated with lower persistence on treatment.

Source: Neurology - November 27, 2017 Category: Neurology Authors: Laroni, A., Signori, A., Maniscalco, G. T., Lanzillo, R., Russo, C. V., Binello, E., Lo Fermo, S., Repice, A., Annovazzi, P., Bonavita, S., Clerico, M., Baroncini, D., Prosperini, L., La Gioia, S., Rossi, S., Cocco, E., Frau, J., Torri Clerici, V., Signor Tags: Multiple sclerosis, All epidemiology ARTICLE Source Type: research